Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Oct 22;14(10):e090224.
doi: 10.1136/bmjopen-2024-090224.

Anticoagulation Therapy Timing in patients with Atrial Fibrillation after Acute and Chronic Subdural Haematoma (ATTAACH): a pilot randomised controlled trial

Alireza Mansouri  1 , Farshad Nassiri  2 , Damon Scales  3 , Farhad Pirouzmand  4
Affiliations

Anticoagulation Therapy Timing in patients with Atrial Fibrillation after Acute and Chronic Subdural Haematoma (ATTAACH): a pilot randomised controlled trial

Alireza Mansouri et al. BMJ Open. .

Abstract

Introduction: Subdural haematomas (SDHs), acute or chronic, are common neurosurgical diagnoses. These problems can occur among patients requiring direct oral anticoagulation (DOAC) for atrial fibrillation. There are currently no guidelines regarding the optimal timing to resume anticoagulation for these patients after SDH. The objective of this study is to evaluate the feasibility of conducting a future large randomised controlled trial (RCT) evaluating the safety and efficacy of resuming DOACs early (ie, at 30 days) vs late (ie, at 3 months) for patients with atrial fibrillation following diagnosis of SDH.

Methods and analysis: This is a pilot, open-label, multicentre RCT that will enrol adults with newly diagnosed acute or chronic SDH with or without other intracranial bleeding who were receiving therapeutic anticoagulation with a DOAC as stroke prophylaxis for atrial fibrillation. Patients will be randomly allocated to resume a DOAC at standard dosing starting either days 30+7 or days 90±14. The primary outcomes for the pilot RCT are recruitment rate, protocol adherence and patient compliance with the randomly allocated interventions. Secondary outcomes are patient functional outcomes and safety and effectiveness outcomes, which will comprise key endpoints for the future planned RCT. This pilot RCT will provide important data to inform the feasibility of conducting a future, large RCT of early versus late resumption of DOACs for atrial fibrillation stroke prophylaxis in patients newly diagnosed with SDH. The future RCT will help inform management of a commonly encountered clinical dilemma with high associated morbidity and mortality.

Ethics and dissemination: This study has been approved by the research ethics board of record. It will be conducted in accordance with the Declaration of Helsinki, Good Clinical Practice guidelines and regulatory requirements. Informed consent will be obtained from eligible patients or substitute decision-makers. Data from this study will inform the design of future, larger RCTs.

Trial registration number: NCT05472766.

Keywords: Anticoagulation; Neurosurgery; Randomized Controlled Trial; Stroke.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

References

    1. Seifi A, Asadi-Pooya AA, Carr K, et al. The epidemiology, risk factors, and impact on hospital mortality of status epilepticus after subdural hematoma in the United States. Springerplus. 2014;3:332. doi: 10.1186/2193-1801-3-332. - DOI - PMC - PubMed
    1. Santarius T, Kirkpatrick PJ, Ganesan D, et al. Use of drains versus no drains after burr-hole evacuation of chronic subdural haematoma: a randomised controlled trial. The Lancet . 2009;374:1067–73. doi: 10.1016/S0140-6736(09)61115-6. - DOI - PubMed
    1. Asghar M, Adhiyaman V, Greenway MW, et al. Chronic subdural haematoma in the elderly--a North Wales experience. J R Soc Med. 2002;95:290–2. doi: 10.1258/jrsm.95.6.290. - DOI - PMC - PubMed
    1. Cousseau DH, Echevarría Martín G, Gaspari M, et al. [Chronic and subacute subdural haematoma. An epidemiological study in a captive population] Rev Neurol. 2001;32:821–4. doi: 10.33588/rn.3209.2000458. - DOI - PubMed
    1. Balser D, Farooq S, Mehmood T, et al. Actual and projected incidence rates for chronic subdural hematomas in United States Veterans Administration and civilian populations. JNS. 2015;123:1209–15. doi: 10.3171/2014.9.JNS141550. - DOI - PMC - PubMed

Publication types

MeSH terms

Associated data